Rational application of targeted therapeutics in mucinous colon/appendix cancers with positive predictive factors
Abstract Molecular‐targeted therapies have demonstrated disappointing results against most advanced solid cancers. This may largey be attributed to irrational drug use against unselected cancers. We investigated the efficacy of dual MEK‐PI3K drug therapy against KRAS mutated mucin 2 (MUC2)‐secreting...
Main Authors: | Ashokkumar Dilly, Brendon D. Honick, Yong J. Lee, David L. Bartlett, Haroon A. Choudry |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2847 |
Similar Items
-
Mucinous cystadenoma of the appendix causing chronic intermittent right iliac fossa pain: case report
by: Serkan Unlu, et al.
Published: (2017-03-01) -
Challenges in diagnosing mucinous neoplasms of appendix: a retrospective observational study
by: P. Nichat, et al.
Published: (2023-09-01) -
Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer
by: Ramesh Pothuraju, et al.
Published: (2020-03-01) -
Mucinous neoplasms of the appendix - A clinicopathologic study of 21 cases with special insight into current classification & controversies.
by: Rajashree Pradhan, et al.
Published: (2023-01-01) -
Durable Response after Repeat Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Patient with Extensive Mucinous Adenocarcinoma of the Appendix
by: Dalia Kaakour, et al.
Published: (2023-04-01)